Blog-Hero

Boost Your Regulatory IQ

Simplify the complex with customized blog posts on life sciences and chemical regulation from AgencyIQ. We bring daily updates and analysis on the things that matter to you—helping you get smarter about regulation on the horizon and your next course of action.

FDA Today
Update to FDA annual reporting requirements for INDs under White House review
FDA finalizes guidance on key definitions under the Drug Supply Chain Security Act

Mar 16, 2023

Read More >>
The Periodic
EPA proposes national primary drinking water regulation for six PFAS

Mar 14, 2023

Read More >>
The Periodic
EU Commission approves nearly 100 chemical safety test methods, streamlines procedure for future additions

Mar 07, 2023

Read More >>
FDA Today
Growing interest in RNA-based medicines may necessitate a new class of pharmaceuticals

Mar 06, 2023

Read More >>
The Periodic
Regulation
DOJ sues Denka, DuPont over Louisiana plant emissions

Mar 02, 2023

Read More >>
FDA Today
FDA wants help with real-world data drug submission standards
FDA publishes discussion paper on AI in drug manufacturing

Mar 01, 2023

Read More >>
The Periodic
Medical image
2021 ban on long-chain PFAS subgroup to take effect

Feb 24, 2023

Read More >>
FDA Today
Amid FDA scrutiny of accelerated approval, sponsors preemptively withdraw products
FDA announces patient-focused drug development meeting on long Covid

Feb 22, 2023

Read More >>
FDA Today
FDA outlines its approach to new meeting types focused on generic drugs

Feb 17, 2023

Read More >>

Get an insider’s view on regulatory movements.

Sign up for AgencyIQ’s newsletters to receive exclusive regulatory updates and analysis impacting the life sciences or chemical industry.

Explore Newsletters